Stay updated on Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision tag updates from v3.4.1 to v3.4.2 with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:49:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. This appears to be a minor maintenance/update with no changes to the study content.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a glossary display option and updated footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous QC label 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4'. The 'No FEAR Act Data' label has been added with updated capitalization compared to the previous 'No FEAR Act data'.
    Difference
    0.2%
    Check dated 2026-01-28T21:44:04.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The change is a minor site version update from v3.3.3 to v3.3.4, with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:43:32.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Recruitment status changed from Recruiting to Active, not recruiting, and the page now includes details on the mpCR composite endpoint and the watchful waiting (WW) option for clinical complete response within the neoadjuvant regimen. New study dates were added (start 2019-04-10; primary completion 2024-10-28; estimated completion 2029-10) and older contact information sections were removed.
    Difference
    2%
    Check dated 2026-01-07T02:02:47.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The footer updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2. These changes do not affect the study details, navigation, or any actionable information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T22:56:15.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.